药物缓释材料

药物缓释材料药物缓释材料
  1. 因其更有效的安全性,聚唾液酸被公认为传统药物缓释材料聚乙二醇(PEG)的理想替代材料。

    Polysialic acid is considered an ideal alternative material of the polyethylene glycol ( PEG ) in controlled-drug release application due to its more effective safety in therapeutics .

  2. 本文研究了药物缓释材料HPMC的合成方法,探讨了碱纤维素制备,醚化剂浓度,混合醚化剂配经以及产品后处理对高粘度HPMC的影响。

    The high viscosity HPMC was prepared as the supplements of medicine . The factors of synthesis , for example alkali cellulose , concentration and ratio of the mixed etherifying agents , and product aftertreatment were studied .

  3. 药物缓释材料的合成与性能

    Synthesis and Properties of Thermosensitive Material Used for Controlled Releasing of Medicine

  4. 羧甲基纤维素钠/阳离子瓜尔胶共混膜用作药物缓释材料的研究

    Study on Biodegradable Blend Films of Cationic Guar Gum and Sodium Carboxymethylcellulose as Ibuprofen-Releasing Matrices

  5. 我们的研究结果显示,这些共聚酸酐具有作为新型药物缓释材料的应用前景。

    These experimental results showed that these copolymer have a potential application value as biomaterials for drug control releasing .

  6. 二异氰酸酯扩链合成聚乳酸类药物缓释材料的研究&Ⅱ.溶液法

    Studies on the Synthesis of Polylactic Acids Drug Delivery Material through Diisocyanate Chain Extension . ⅱ . Solution Method

  7. 高岭石插层复合物作为一种新型的纳米复合材料,在高性能聚合物基复合材料、电化学功能材料、非线性光学材料、药物缓释材料等方面具有潜在应用价值。

    As a novel nanocomposite material , kaolinite intercalation compound has potential applications in high-performance polymer matrix composite materials , electrochemical functional materials , nonlinear optical materials and drug delivery materials .

  8. 介绍了聚乳酸在生物医学工程领域的应用,如药物缓释材料、骨固定材料、手术缝合线、眼科材料等,对其在生物医学领域的研究前景作了展望。

    The application of polylactide in biomedical field was introduced , such as medicine slow release , bone screw fixation , surgical suture , ophthalmic material . And the prospects were outlooked .

  9. 新型药物缓释材料的合成及纳米微球的制备木质素来源于造纸废液,作为钾肥的缓释材料,其资源环保意义重大。

    Synthesis of a New Type of Drug Delivery Material and Preparation of Nanoparticles Lignin from paper-making waste liquor was used as slow-releasing material to potassium fertilizer , which was propitious to resources utilization and environmental protection .

  10. 理化性质表征结果显示:合成的醚酐共聚物具有分子量高,熔点较低,热稳定性较好等作为药物缓释材料必备的性能。

    The physical and chemical properties showed that all the prepared poly ( ether-anhydrides ) meet the essential requirement for polyanhydrides as drug delivery material including high molecular weights , low melting points , and desired thermal stability .

  11. 因此可见,含有纳米阀门控制器的空心球介孔材料可望在药物缓释应用材料中担当一个重要角色。

    Therefore , the hollow sphere mesoporous silica with nanovalves will potentially play an important role in the application of drug delivery .

  12. 目前尚无一种既能够防止硬膜外粘连,又同时起到药物缓释作用的材料。

    There has not been a material which could prevent peridural fibrosis and delay the release of medicine .

  13. 然而,作为药物缓释的载体材料,水凝胶的大小、形态、智能性和生物降解性等必须满足实际要求并能进行调节,因此水凝胶的制备就显得尤为重要。

    The properties of hydrogels , such as size , morphology , intelligence and biodegradability , need to meet the practical requirements , and the preparation techniques are rather important .

  14. 聚乳酸作为生物可降解材料的一种,对环境友好、无毒害,可应用于组织工程、药物缓释等生物医用材料,以及石油基塑料的替代材料。

    As one of the biodegradable materials , poly ( lactic acid ) ( PLA ) is nontoxic to environment and the human body . It can be used in tissue engineering , drug delivery system , as well as the substitute for the petroleum-based plastics .

  15. 这些聚集体被用在药物运输、药物缓释、生物材料及组织工程等领域。

    They are used in the area of drug delivery , drug release , biomaterials and tissue engineering , et al .

  16. 在制药领域,环糊精可以用于改善药物的水溶性和稳定性;环糊精还可以用于药物缓释材料控制药物的释放。

    In the pharmaceutical field , cyclodextrins are used essentially for improving drug stability and dissolution rates ; cyclodextrins could also modify drug release profile from many controlled release drug delivery systems .

  17. 综述了近年来国内外壳聚糖因其不同的生物特性在胃溃疡药物中的应用研究进展,包括壳聚糖抗酸作用、抗幽门螺杆菌、保护胃粘膜等作用以及壳聚糖作为药物缓释材料。

    The objective of this review is to summarize the recent applications of chitosan in gastric ulcer treatment , utilizing the properties of chitosan such as antiacid , anti-Helicobacter pylori , protecting gastric mucosa and using chitosan as a candidate for the development of novel drug delivery system .